Close
Nordic 9Nordic 9

Quell Therapeutics (private company)

United Kingdom
See something wrong or missing? Let us know
Offices:London
Industry:BiotechHealth servicesManufacturing
Business model:B2B

Quell Therapeutics is developing engineered T-regulatory (Treg) cell therapies that aim to harness, direct and optimize their immune suppressive properties to address serious medical conditions driven by the immune system.

Investors: we tracked 12 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 266.17M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Quell Therapeutics

Name Criteria
Germany CatalYm
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
France InnovaFeed SAS
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 7
  • Total raised in a similar range: 10M+ USD
United Kingdom Peptone
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Netherlands Salvia BioElectronics
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Austria Sarcura
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Switzerland Synendos Therapeutics
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 5
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
France Eyevensys
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Mestag Therapeutics
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany Emergence Therapeutics
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 6
  • Total raised in a similar range: 10M+ USD
Top